“Africa needs to come to grips with owning her future.” This insight from futures thinker Dr. Geci Karuri-Sebina is pivotal to her work and sense of purpose. Karuri-Sebina wants to see deliberate futures thinking integrated into every level of African society. She is hopeful that the right...
UCB has a rich heritage in epilepsy, with over 30 years of experience in the research, development and delivery of antiseizure medications. As a company with a long-term commitment to epilepsy research, we want to contribute to solutions that address unmet medica...
On Dec. 25, 2020, orelabrutinib received approval from the China National Medical Products Administration (NMPA) in two indications: the treatment of patients with relapsed/refractory chronic lymphocytic leukemia (CLL) /small lymphocytic lymphoma (SLL) and the treatment of patients with relapsed/refr...
The Forbes Midas List celebrates honorees' extraordinary investment insights and accomplishments. Nisa and her team have shown a strong commitment to identifying startups that enhance the healthcare system while addressing global unmet medical needs. Over the past decade, Nisa and her team have over...
the WHO released the Fungal Priority Pathogens List, identifying 19 critical, high, and medium priority fungal pathogens. Recognition of the global public health impact of fungal infection may raise clinical awareness, address unmet research needs on antifungal agents, and improve infection surveillance ...
Disitamab Vedotin (RC48) is an anti-HER2 antibody-drug conjugate targeting prevalent cancers with significant unmet medical needs, and is the first domestically developed ADC inChinato receive marketing approval. The drug was granted condi...
Need analysis and unmet needs Purchase and usage behavior Partner/customer feedback and satisfaction Ask us anything Competitive Analysis of Best Companies in US Photonics Market US Photonics Market: Competitive Landscape Market Characteristics:The US Photonics Market consists of a diverse range of com...
Everest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets...
(NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based inChinaandthe United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in ...
That responsibility includes tackling some of the world’s most pressing unmet healthcare needs, such as a commitment to innovating treatments for deadly diseases, working to advance health equity across the globe and improving environmental health—just to name a few.The company is honored to be ...